Japan-based pharmaceutical company, Daiichi Sankyo, and Japan corporate investment unit Mitsubishi UFJ Capital have launched a new open innovation business through the Organization for Small & Medium Enterprises and Regional Innovation (OiDE Fund Investment Limited Partnership). The fund will be operated by Mitsubishi UFJ Capital with combined commitments of YEN750m ($7.5m).
Daiichi Sankyo has committed YEN100m ($1m) and Mitsubishi UFJ Capital will be investing as much as YEN200m ($2m) with the Organization for Small & Medium Enterprises and Regional Innovation…
